CompletedPhase 4NCT04414267
Bacillus Calmette-guérin Vaccination to Prevent COVID-19
Studying Chronic graft versus host disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Principal Investigator
- Antonios Papadopoulos, MD, PhDNational Kapodistrian University of Athens, Medical School
- Intervention
- BCG vaccine(biological)
- Enrollment
- 301 enrolled
- Eligibility
- 50 years · All sexes
- Timeline
- 2020 – 2021
Study locations (15)
- General Hospital of Argolida - Nafplion Unit, Nafplion, Argos, Greece
- 2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupoli, Greece
- Department of Therapeutics, Alexandra General Hospital, Athens, Greece
- 1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece
- 2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece
- 3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece
- 4th Department of Internal Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece
- Department of Pulmonary Medicine- General Hospital of Kerkyra, Corfu, Greece
- General Hospital of Korinthos, Corinth, Greece
- 1st Department of Internal Medicine, General University Hospital of Ioannina, Ioannina, Greece
- Department of Internal Medicine, General Hospital of Karditsa, Karditsa, Greece
- Department of Internal Medicine, Patras University Hospital, Pátrai, Greece
- General Hospital of Ptolemaida MPODOSAKEIO, Ptolemaida, Greece
- 1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloniki, Greece
- General Hospital of Imathia - Veria Unit, Véria, Greece
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04414267 on ClinicalTrials.govOther trials for Chronic graft versus host disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07394608Paired Non-invasive VNS in Adolescent Cerebral Palsy RehabilitationIcahn School of Medicine at Mount Sinai
- RECRUITINGPHASE2NCT07124078A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)Incyte Corporation
- RECRUITINGEARLY PHASE1NCT07355868Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell TherapyRegend Therapeutics
- RECRUITINGNANCT06857929"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"IMDEA Food
- RECRUITINGPHASE1NCT07389044A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis BIntegerBio
- RECRUITINGNCT07127926Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHDM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT07138196A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host DiseaseQurient Co., Ltd.
- ACTIVE NOT RECRUITINGNCT07321080Central Sensitisation in Nociceptive and Neuropathic PainIRCCS Centro Neurolesi Bonino Pulejo